This study investigated clinical, laboratorial, therapeutic and prognostic aspects of American
cutaneous leishmaniasis in Belo Horizonte in 358 patients with cutaneous leishmaniasis …

A non-randomized controlled clinical trial was carried outin order to evaluate both
azithromycin and antimony efficacy in cutaneous leishmaniasis in Manaus, AM, Brazil. Forty …

This study compared the efficacies of two N-methylglucomine antimoniate (MA) dose
regimens for treating macaques with Leishmania braziliensis-induced chronic skin disease …

Ninety military patients with cutaneous leishmaniasis in Colombia were randomly allocated
to 3 treatment regimens of parenteral aminosidine sulphate:(i) 12 mg aminosidine base/kg/d …

Two hundred twenty-six consecutive adult patients with cutaneous leishmaniasis in
Colombia were treated with Glucantime and 81% were cured. The 19% who failed treatment …

Antimony-based medications continue to be the chosen drug for visceral leishmaniasis
treatment in most countries. Pentavalent antimony compounds are highly effective but …

BACKGROUND Cutaneous leishmaniasis (CL) is a world-wide health problem which
currently lacks effective, affordable and easy to use therapy. Recently, the meglumine …

Ninety‐six patients with a clinical and parasitological diagnosis of cutaneous leishmaniasis
were recruited to a comparative randomized clinical trial evaluating the efficacy of topical …

This is a case report of a Brazilian soldier with cutaneous leishmaniasis. The lesion relapsed
following two systemic treatments with meglumine antimoniate. The patient was treated with …

American tegumentary leishmaniasis is an infectious disease caused by a protozoan of the
genus Leishmania. Pentavalent antimonials are the first choice drugs for cutaneous …